| Dr Akinrinola Fatoki, MD | |
|
11125 Dunn Rd, Suite 201, Saint Louis, MO 63136-6132 | |
| (314) 355-5300 | |
| (314) 355-1177 |
| Full Name | Dr Akinrinola Fatoki |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 35 Years |
| Location | 11125 Dunn Rd, Saint Louis, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346354693 | NPI | - | NPPES |
| 208030767 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 109044 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christian Hospital Northeast | Saint louis, MO | Hospital |
| Ssm Depaul Health Center | Bridgeton, MO | Hospital |
| Entity Name | State Of Missouri |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710931167 PECOS PAC ID: 1456254226 Enrollment ID: O20041208000473 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, today announced that they have entered into a licensing agreement granting exclusive rights to Norgine to develop, manufacture and commercialize prescription immediate-release ZEGERID® products incorporating the proton pump inhibitor omeprazole in combination with one or more buffering agents in specified markets in Western, Central and Eastern Europe.
Oncotarget recently published "PD-1/PD-L1 expression in anal squamous intraepithelial lesions" which reported that the presence and distribution of CD8 lymphocytes and the presence of PD-1 lymphocytes and PD-L1 epithelial cells were assessed.
The findings of a journal article published in the May issue of the Archives of Surgery are fundamentally flawed and could undermine patients ability to find high quality hospital care, according to HealthGrades. The article, Evaluating Popular Media and Internet-Based Hospital Quality Ratings for Cancer Surgery, compared outcomes for gastrointestinal cancer patients who underwent surgery at hospitals on HealthGrades' "America's 50 Best Hospitals" and US News and World Report's "America's Best Hospitals" lists.
Waters Corporation has posted a new version of its online video showcase featuring compelling interviews with more than 50 scientists, development partners, and product experts in the fields of pharmaceutical discovery and development, food safety, environmental analysis, sports medicine, disease research and clinical toxicology and clinical research.
› Verified 4 days ago
| Entity Name | Mcpherson Medical & Diagnostic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003407883 PECOS PAC ID: 5698773539 Enrollment ID: O20061201000167 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, today announced that they have entered into a licensing agreement granting exclusive rights to Norgine to develop, manufacture and commercialize prescription immediate-release ZEGERID® products incorporating the proton pump inhibitor omeprazole in combination with one or more buffering agents in specified markets in Western, Central and Eastern Europe.
Oncotarget recently published "PD-1/PD-L1 expression in anal squamous intraepithelial lesions" which reported that the presence and distribution of CD8 lymphocytes and the presence of PD-1 lymphocytes and PD-L1 epithelial cells were assessed.
The findings of a journal article published in the May issue of the Archives of Surgery are fundamentally flawed and could undermine patients ability to find high quality hospital care, according to HealthGrades. The article, Evaluating Popular Media and Internet-Based Hospital Quality Ratings for Cancer Surgery, compared outcomes for gastrointestinal cancer patients who underwent surgery at hospitals on HealthGrades' "America's 50 Best Hospitals" and US News and World Report's "America's Best Hospitals" lists.
Waters Corporation has posted a new version of its online video showcase featuring compelling interviews with more than 50 scientists, development partners, and product experts in the fields of pharmaceutical discovery and development, food safety, environmental analysis, sports medicine, disease research and clinical toxicology and clinical research.
› Verified 4 days ago
| Entity Name | Bahm Family Medicine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184839136 PECOS PAC ID: 7113028044 Enrollment ID: O20070723000502 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, today announced that they have entered into a licensing agreement granting exclusive rights to Norgine to develop, manufacture and commercialize prescription immediate-release ZEGERID® products incorporating the proton pump inhibitor omeprazole in combination with one or more buffering agents in specified markets in Western, Central and Eastern Europe.
Oncotarget recently published "PD-1/PD-L1 expression in anal squamous intraepithelial lesions" which reported that the presence and distribution of CD8 lymphocytes and the presence of PD-1 lymphocytes and PD-L1 epithelial cells were assessed.
The findings of a journal article published in the May issue of the Archives of Surgery are fundamentally flawed and could undermine patients ability to find high quality hospital care, according to HealthGrades. The article, Evaluating Popular Media and Internet-Based Hospital Quality Ratings for Cancer Surgery, compared outcomes for gastrointestinal cancer patients who underwent surgery at hospitals on HealthGrades' "America's 50 Best Hospitals" and US News and World Report's "America's Best Hospitals" lists.
Waters Corporation has posted a new version of its online video showcase featuring compelling interviews with more than 50 scientists, development partners, and product experts in the fields of pharmaceutical discovery and development, food safety, environmental analysis, sports medicine, disease research and clinical toxicology and clinical research.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Akinrinola Fatoki, MD 23 Chamblee Ln, Creve Coeur, MO 63141-7321 Ph: (314) 205-2360 | Dr Akinrinola Fatoki, MD 11125 Dunn Rd, Suite 201, Saint Louis, MO 63136-6132 Ph: (314) 355-5300 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, and Norgine B.V., a European specialty pharmaceutical company, today announced that they have entered into a licensing agreement granting exclusive rights to Norgine to develop, manufacture and commercialize prescription immediate-release ZEGERID® products incorporating the proton pump inhibitor omeprazole in combination with one or more buffering agents in specified markets in Western, Central and Eastern Europe.
Oncotarget recently published "PD-1/PD-L1 expression in anal squamous intraepithelial lesions" which reported that the presence and distribution of CD8 lymphocytes and the presence of PD-1 lymphocytes and PD-L1 epithelial cells were assessed.
The findings of a journal article published in the May issue of the Archives of Surgery are fundamentally flawed and could undermine patients ability to find high quality hospital care, according to HealthGrades. The article, Evaluating Popular Media and Internet-Based Hospital Quality Ratings for Cancer Surgery, compared outcomes for gastrointestinal cancer patients who underwent surgery at hospitals on HealthGrades' "America's 50 Best Hospitals" and US News and World Report's "America's Best Hospitals" lists.
Waters Corporation has posted a new version of its online video showcase featuring compelling interviews with more than 50 scientists, development partners, and product experts in the fields of pharmaceutical discovery and development, food safety, environmental analysis, sports medicine, disease research and clinical toxicology and clinical research.
› Verified 4 days ago
Mrs. Jetuan L Rowley-herron, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 5471 Dr Martin Luther King Dr, Saint Louis, MO 63112 Phone: 314-367-5820 Fax: 314-367-7010 | |
Amy Elizabeth Roberts, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8888 Ladue Rd Ste 210, Saint Louis, MO 63124 Phone: 314-996-5900 Fax: 314-995-5910 | |
Christopher Brian Espana, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5034 Griffin Rd, Saint Louis, MO 63128 Phone: 314-843-7333 Fax: 314-843-9946 | |
Mrs. Teresita Agustin Cometa, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 5471 Dr Martin Luther King Dr, Saint Louis, MO 63112 Phone: 314-367-5820 Fax: 314-367-6326 | |
Dr. Michael T Railey, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6125 Clayton Ave, Ste 222, Saint Louis, MO 63139 Phone: 314-768-3685 Fax: 314-768-3940 | |
Dr. Alan Valente A Padua, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13303 Tesson Ferry Rd Ste 100, Saint Louis, MO 63128 Phone: 314-722-4741 Fax: 314-722-4731 | |
Anne Usha Jacob, M.B.B.S. Family Medicine Medicare: Medicare Enrolled Practice Location: 3649 Page Blvd, Saint Louis, MO 63113 Phone: 314-288-0071 Fax: 314-758-5210 |